san 202791 has been researched along with 1,4-dihydropyridine in 4 studies
Studies (san 202791) | Trials (san 202791) | Recent Studies (post-2010) (san 202791) | Studies (1,4-dihydropyridine) | Trials (1,4-dihydropyridine) | Recent Studies (post-2010) (1,4-dihydropyridine) |
---|---|---|---|---|---|
31 | 0 | 2 | 1,115 | 23 | 221 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bodi, I; He, M; Mikala, G; Schwartz, A | 1 |
Bodi, I; Hara, M; He, M; Schwartz, A; Varadi, G; Yamaguchi, H | 1 |
Kan, E; Kelly, JE; Lokuta, AJ; Nishio, M; Sagawa, K; Sagawa, T; Tsai, J; Wasserstrom, JA | 1 |
Chahine, M; Sculptoreanu, A; Varma, DR | 1 |
4 other study(ies) available for san 202791 and 1,4-dihydropyridine
Article | Year |
---|---|
Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
Topics: Amino Acid Sequence; Animals; Barium; Binding Sites; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Female; Humans; Membrane Potentials; Molecular Sequence Data; Mutagenesis, Site-Directed; Oocytes; Point Mutation; Radioligand Assay; Recombinant Fusion Proteins; Xenopus laevis | 1997 |
Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels. Critical involvement of tyrosine residues in motif IIIS6 and IVS6.
Topics: Animals; Barium; Calcium Channels; Calcium Channels, L-Type; Dihydropyridines; Female; Isoleucine; Membrane Potentials; Mutagenesis, Site-Directed; Myocardium; Oocytes; Point Mutation; Polymerase Chain Reaction; Rabbits; Stereoisomerism; Xenopus laevis | 1997 |
Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism | 2001 |
Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
Topics: Animals; Animals, Newborn; Azocines; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Myocytes, Cardiac; Patch-Clamp Techniques; Rats | 2003 |